PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26572488-6	2015	Sorafenib significantly inhibited the expression of angiogenesis-associated cell markers and cytokines, including CD31, von Willebrand factor (vWF), and vascular endothelial growth factor, whereas GdCl3 suppressed macrophage-related cell markers and cytokines, including CD68, tumor necrosis factor-alpha, interleukin-1beta, and CCL2.	Sorafenib	0-9	platelet and endothelial cell adhesion molecule 1	Rattus norvegicus	114-118	
26572488-6	2015	Sorafenib significantly inhibited the expression of angiogenesis-associated cell markers and cytokines, including CD31, von Willebrand factor (vWF), and vascular endothelial growth factor, whereas GdCl3 suppressed macrophage-related cell markers and cytokines, including CD68, tumor necrosis factor-alpha, interleukin-1beta, and CCL2.	Sorafenib	0-9	von Willebrand factor	Rattus norvegicus	120-141	
26572488-6	2015	Sorafenib significantly inhibited the expression of angiogenesis-associated cell markers and cytokines, including CD31, von Willebrand factor (vWF), and vascular endothelial growth factor, whereas GdCl3 suppressed macrophage-related cell markers and cytokines, including CD68, tumor necrosis factor-alpha, interleukin-1beta, and CCL2.	Sorafenib	0-9	von Willebrand factor	Rattus norvegicus	143-146	
26572488-6	2015	Sorafenib significantly inhibited the expression of angiogenesis-associated cell markers and cytokines, including CD31, von Willebrand factor (vWF), and vascular endothelial growth factor, whereas GdCl3 suppressed macrophage-related cell markers and cytokines, including CD68, tumor necrosis factor-alpha, interleukin-1beta, and CCL2.	Sorafenib	0-9	Cd68 molecule	Rattus norvegicus	271-275	
26572488-6	2015	Sorafenib significantly inhibited the expression of angiogenesis-associated cell markers and cytokines, including CD31, von Willebrand factor (vWF), and vascular endothelial growth factor, whereas GdCl3 suppressed macrophage-related cell markers and cytokines, including CD68, tumor necrosis factor-alpha, interleukin-1beta, and CCL2.	Sorafenib	0-9	tumor necrosis factor	Rattus norvegicus	277-304	
26572488-6	2015	Sorafenib significantly inhibited the expression of angiogenesis-associated cell markers and cytokines, including CD31, von Willebrand factor (vWF), and vascular endothelial growth factor, whereas GdCl3 suppressed macrophage-related cell markers and cytokines, including CD68, tumor necrosis factor-alpha, interleukin-1beta, and CCL2.	Sorafenib	0-9	interleukin 1 beta	Rattus norvegicus	306-323	
26572488-6	2015	Sorafenib significantly inhibited the expression of angiogenesis-associated cell markers and cytokines, including CD31, von Willebrand factor (vWF), and vascular endothelial growth factor, whereas GdCl3 suppressed macrophage-related cell markers and cytokines, including CD68, tumor necrosis factor-alpha, interleukin-1beta, and CCL2.	Sorafenib	0-9	C-C motif chemokine ligand 2	Rattus norvegicus	329-333	
26572488-7	2015	Laser confocal microscopy showed that sorafenib inhibited vWF expression and GdCl3 reduced CD68 staining.	Sorafenib	38-47	von Willebrand factor	Rattus norvegicus	58-61	
26572488-7	2015	Laser confocal microscopy showed that sorafenib inhibited vWF expression and GdCl3 reduced CD68 staining.	gadolinium chloride	77-82	Cd68 molecule	Rattus norvegicus	91-95